>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
克隆猿猴病毒40增强子修饰人乙酰肝素酶基因核心启动子及活性分析
作者:王永1  陈晓鹏1 2 
单位:1. 南京市浦口区中医院 普外科,江苏 南京 211800;
2. 皖南医学院附属弋矶山医院 肝胆外科,安徽 芜湖 241000
关键词:乙酰肝素酶 启动子 增强子 
分类号:R-33
出版年·卷·期(页码):2012·31·第一期(12-18)
摘要:

目的:克隆猿猴病毒40(simian virus 40, SV40)增强子序列,修饰人乙酰肝素酶(heparanase, HPSE)基因核心启动子,并分析其活性。方法:PCR扩增SV40增强子序列并测序鉴定,酶切连接插入到pEGFP-HPSEp中指定克隆位点构建重组质粒pEGFP-HPSEp-SV40enh。将原质粒、重组质粒和阳性对照质粒分别转染肝癌细胞(HepG2)、喉癌上皮细胞(Hep2)和慢性白血病细胞(K562)。荧光显微镜观察和流式细胞术分析各质粒促转录活性。结果:扩增的SV40增强子序列长度为237 bp,序列分析与GeneBank收录一致。重组质粒pEGFP-HPSEp-SV40enh经酶切和测序鉴定与预期结果一致,SV40增强子序列插入到指定克隆位点。荧光显微镜观察显示,转染pEGFP-HPSEp-SV40enh的HepG2、Hep2和K562细胞均有较强荧光表达;转染pEGFP-HPSEp的细胞荧光强度均较弱。流式细胞术检测表明,pEGFP-HPSEp-SV40enh在HepG2、Hep2和K562细胞的平均转染率分别为3.7%、6.0%和5.5%,pEGFP-HPSEp转染率分别为4.8%、13.4%和7.7%,两者比值均小于1。结论:成功克隆了SV40增强子序列并构建了重组质粒pEGFP-HPSEp-SV40enh,SV40增强子可以初步提高HPSE启动子的活性。

Objective: To modify heparanase gene core promoter with amplified SV40 enhancer DNA sequence and analyze its activity. Methods: SV40 enhancer sequence was amplified and inserted into the multiple clone site of pEGFP-HPSEp to construct a recombinant plasmids named pEGFP-HPSEp-SV40enh. The vector driven by HPSEp-SV40enh and HPSEp were transfected into human tumor cell lines including hepatoma carcinoma cell line(HepG2), laryngocarcinoma cell line(Hep2) and chronic myelogenous leukemia cell line(K562), respectively. The activity of reporter gene GFP was detected using fluorescence microscope and flow cytometry after transfection. Results: The length of amplified SV40 enhancer was 237 bp and the sequence was accordant with the GeneBank data. The enzyme result of digestion and sequencing of the constructed vector pEGFP-HPSEp-SV40enh was consistent with the expectation, SV40 enhancer sequence was inserted into the allocated multiple clone site. Fluorimetric analysis revealed that hyperfluorescence was found in pEGFP-HPSEp-SV40enh group and less fluorescence was found in pEGFP-HPSEp group,The average transfection efficiencies of GFP-HPSEp-SV40enh in HepG2, Hep2 and K562 cells were 3.7%, 6.0% and 5.5%, respectively, while those of pEGFP-HPSEp were 4.8%, 13.4% and 7.7%, respectively, with all the ratios of them less than 1. Conclusions: SV40 enhancer sequence is amplified successfully and pEGFP-HPSEp-SV40enh could be successfully constructed, SV40 enhancer might improve the activity of HPSE promoter.

参考文献:

[1] 杨玉捷,张亚历.乙酰肝素酶——癌细胞浸润、转移的一个关键酶[J].肿瘤,2004,24(1):82-83.
[2] 胡良鹤,陈晓鹏.人乙酰肝素酶核心启动子的扩增及序列分析[J].皖南医学院学报,2009,28(5):319-322.
[3] LI H S,LIU Y,LI D F,et al.Enhancement of DNA vaccine-induced immune responses by a 72-bp element from SV40 enhancer[J]. Chin Med J, 2007,120(6):496-502.
[4] 栾琪,孙静,高天文.乙酰肝素酶在恶性肿瘤的表达调控研究进展[J].肿瘤学杂志,2008,14(10):856-859.
[5] 陈晓鹏,胡良鹤,王永.人乙酰肝素酶基因启动子驱动的真核细胞表达载体的构建和功能分析[J].上海交通大学学报:医学版,2010,30(3):176-178.
[6] 王丽娜,李卓,薛志刚,等.用原核增强子提高hTERT启动子介导的基因表达[J].中华肿瘤防治杂志,2006,13(15):1125-1130.
[7] 石秦东,张蓬勃,康前雁,等.以EGFP为报告基因的增强子鉴定质粒载体的构建及鉴定[J].南方医科大学学报,2007,27(12):1834-1837.
[8] 张维铭,薛丽英,徐垚,等.SV40增强子修饰提高人端粒酶逆转录酶启动子的转录活性[J].中华病理学杂志,2006,35(11):691-693.
[9] 王永,陈晓鹏.肿瘤特异性启动子驱动的RNA干扰与肿瘤基因靶向治疗[J].国际肿瘤学杂志,2009,36(12):894-896.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 418860 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364